| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 280.04B | 281.35B | 275.57B | 262.50B | 280.85B |
| Gross Profit | 52.28B | 171.01B | 165.68B | 45.26B | 57.23B |
| EBITDA | 66.10B | 48.58B | 85.14B | 65.42B | 77.94B |
| Net Income | 11.84B | 17.09B | 23.50B | 36.68B | 33.48B |
Balance Sheet | |||||
| Total Assets | 1.16T | 1.11T | 1.16T | 1.15T | 1.21T |
| Cash, Cash Equivalents and Short-Term Investments | 143.75B | 121.31B | 127.32B | 138.09B | 153.13B |
| Total Debt | 334.28B | 324.73B | 343.53B | 353.42B | 412.06B |
| Total Liabilities | 467.28B | 459.95B | 488.35B | 505.69B | 581.68B |
| Stockholders Equity | 562.77B | 534.72B | 548.60B | 523.51B | 513.15B |
Cash Flow | |||||
| Free Cash Flow | 43.82B | 33.86B | 26.14B | 30.55B | 12.05B |
| Operating Cash Flow | 62.57B | 54.23B | 51.44B | 56.40B | 51.69B |
| Investing Cash Flow | -6.11B | -19.90B | -15.41B | -5.17B | -2.41B |
| Financing Cash Flow | -34.01B | -40.35B | -46.78B | -66.27B | -52.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | HK$104.31B | 28.96 | 1.14% | 5.26% | 6.44% | -95.37% | |
65 Neutral | HK$15.38B | 7.75 | 4.07% | 6.37% | -7.44% | -18.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$241.68B | 17.13 | 2.12% | 4.02% | 1.93% | -65.62% | |
62 Neutral | HK$356.36B | 5.51 | 5.53% | 5.15% | 2.45% | -0.36% | |
60 Neutral | HK$39.48B | 7.30 | 5.66% | 4.94% | ― | ― | |
42 Neutral | HK$34.11B | -1.40 | -21.69% | 0.44% | -8.93% | -698.78% |